Insider · CIK 0001376960
Jason Aryeh
Files at LGND (LIGAND PHARMACEUTICALS INC), LFCR (LIFECORE BIOMEDICAL, INC. \DE\), OBIO (Orchestra BioMed Holdings, Inc.), ANEB (Anebulo Pharmaceuticals, Inc.). First filing Sep 19, 2025, latest Sep 24, 2025.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
LGND: LIGAND PHARMACEUTICALS INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
OBIO: Orchestra BioMed Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | LIGAND PHARMACEUTICALS INC | $1.7M 10,000 shares | -13% | +77% from low-0% from high | |
| 28Weak | OBIObuy Orchestra BioMed Holdings, Inc. | $2,450 1,000 shares | +1% | +1% from low-62% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 8, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Common Stock | +2,034 | $69.51 | $141k | 71,323 | Dec 8, 2025 |
| Dec 8, 2025 | LGND LIGAND PHARMACEUTICALS INC | MOption exercise Non-Qualified Stock Option (right to buy)derivative | -2,034 | $0.00 | $0 | 0 | Dec 8, 2025 |
| Sep 23, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -4,418 | $170.41 | $753k | 74,871 | Sep 24, 2025 |
| Sep 23, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -4,628 | $170.96 | $791k | 70,243 | Sep 24, 2025 |
| Sep 23, 2025 | LGND LIGAND PHARMACEUTICALS INC | SOpen-market sale Common Stock | -954 | $171.92 | $164k | 69,289 | Sep 24, 2025 |
| Sep 19, 2025 | OBIO Orchestra BioMed Holdings, Inc. | POpen-market purchase Common Stock, par value $0.0001 per share | +1,000 | $2.45 | $2,450 | 108,482 | Sep 19, 2025 |
| Aug 7, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +15,000 | $0.00 | $0 | 107,482 | Aug 8, 2025 |
| Jul 15, 2025 | LFCR LIFECORE BIOMEDICAL, INC. \DE\ | AGrant or award Common Stock | +19,506 | - | - | 44,060 | Jul 17, 2025 |
| Jun 24, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Common Stock, par value $0.0001 per share ("Common Stock") | +12,422 | $0.00 | $0 | 92,482 | Jun 27, 2025 |
| Jun 24, 2025 | OBIO Orchestra BioMed Holdings, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +36,797 | $0.00 | $0 | 36,797 | Jun 27, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Common Stock | +1,209 | $0.00 | $0 | 79,289 | Jun 10, 2025 |
| Jun 6, 2025 | LGND LIGAND PHARMACEUTICALS INC | AGrant or award Non-Qualified Stock Option (right to buy)derivative | +5,783 | $0.00 | $0 | 5,783 | Jun 10, 2025 |
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Apr 7, 2025 |
| Apr 4, 2025 | ANEB Anebulo Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +4,964 | $0.00 | $0 | 4,964 | Apr 7, 2025 |
| Dec 27, 2024 | OBIO Orchestra BioMed Holdings, Inc. | MOption exercise Common Stock, par value $0.0001 per share ("Common Stock") | +11,700 | $4.30 | $50k | 80,060 | Dec 30, 2024 |
| Dec 27, 2024 | OBIO Orchestra BioMed Holdings, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -11,700 | $0.00 | $0 | 6,900 | Dec 30, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.